SUNPHARMA

What Sun Pharmaceutical Industries promised, and what happened

Every commitment management made on a call, tracked from the quarter it was made — reaffirmed, revised, diluted or quietly dropped.

Guidance record · Q1 FY27

what the last two calls moved 15 tracked 6 delivered 3 missed 6 open
  • Consolidated Topline Growth delivered said Q4 FY25 Promised: mid to high single digit Q1 FY27: The Q1 FY27 call was focused on the Organon acquisition and did not provide final FY26 results.
  • Synergy realization from Organon acquisition open said Q1 FY27 Promised: $350 million Q1 FY27: There are also significant potential synergies that could come out, which we have highlighted could be in the range of about $350 million which could be materialized in the next two to four years.

The rest of the ledger

Above is what the last two calls moved. Pro opens all 15 tracked commitments for Sun Pharmaceutical Industries — every quarter's revision, the source quote behind each one, and the topics management has stopped answering.

See what Pro opens